Sign in
4/A

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001209191-20-022237

CFO and Treasurer acquired 4,250 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Krognes Steve E. CFO and Treasurer 2020-02-07 Option exercise +4,250 1,007,916 D
Derivatives
Krognes Steve E. CFO and Treasurer 2020-02-07 Option exercise · Restricted Stock Units −4,250 12,750 D
Loading xslF345X03/doc4a.xml…